• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Live UK pricing:

Nuformix PLC (NFX)

ORD 0.05P
Sell: 0.10p|Buy: 0.12p|Change: 0.01 (-4.35%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Company profile

Nuformix PLC is a pharmaceutical development company. It operates in pharmaceutical development, targeting unmet medical needs in fibrosis and oncology through drug repurposing. Its pipeline products include NXP001, NXP002, and NXP004. Geographically, the company operates only in the UK.

Address

60 Gracechurch Street
6th Floor
London
GBR
EC3V 0HR

Telephone

+44 1223627222

Website

https://www.nuformix.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Nuformix PLC Second Quarter Earnings Results for 20272027-05-28T00:00:00
Nuformix PLC Annual General Meeting for 20272027-03-03T08:30:00
Nuformix PLC Annual Report for 20262027-02-12T00:00:00
Nuformix PLC Fourth Quarter Earnings Results for 20262027-01-27T00:00:00

Previous key dates

NameKey Date
Nuformix PLC Second Quarter Earnings Results for 20262026-05-28T00:00:00
Nuformix PLC Annual General Meeting for 20262026-03-03T08:30:00
Nuformix PLC Annual Report for 20252026-02-13T00:00:00
Nuformix PLC Fourth Quarter Earnings Results for 20252026-01-27T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.